Company attributes
Location
B2X
Founder
Legal Name
Axiogenesis AG
Number of Employees (Ranges)
11 – 50
Full Address
Nattermannallee 1, Building S20 50829 Cologne Germany
Investors
Founded Date
2000
0Latest Funding Round Date
May 2016
Latest Funding Type
Patents Assigned (Count)
1
Other attributes
Company Operating Status
Closed
Axiogenesis was a company that engaged in the development and commercialization of in vitro models of healthy and diseased cell types and tissue. It developed stem cell-derived, in vitro differentiated cardiomyocytes, neurons and other cell types.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.

